The
prenylated isoflavones 5-deoxyprenylbiochanin A (7-hydroxy-4′-methoxy-3′-prenylisoflavone)
and erysubin F (7,4′-dihydroxy-8,3′-diprenylisoflavone)
were synthesized for the first time, starting from mono- or di-O-allylated chalcones, and the structure of 5-deoxy-3′-prenylbiochanin
A was corroborated by single-crystal X-ray diffraction analysis. Flavanones
are key intermediates in the synthesis. Their reaction with hypervalent
iodine reagents affords isoflavones via a 2,3-oxidative rearrangement
and the corresponding flavone isomers via 2,3-dehydrogenation. This
enabled a synthesis of 7,4′-dihydroxy-8,3′-diprenylflavone,
a non-natural regioisomer of erysubin F. Erysubin F (8), 7,4′-dihydroxy-8,3′-diprenylflavone (27), and 5-deoxy-3′-prenylbiochanin A (7) were
tested against three bacterial strains and one fungal pathogen. All
three compounds are inactive against Salmonella enterica subsp. enterica (NCTC 13349), Escherichia
coli (ATCC 25922), and Candida albicans (ATCC
90028), with MIC values greater than 80.0 μM. The diprenylated
natural product erysubin F (8) and its flavone isomer
7,4′-dihydroxy-8,3′-diprenylflavone (27) show in vitro activity against methicillin-resistant Staphylococcus
aureus (MRSA, ATCC 43300) at MIC values of 15.4 and 20.5
μM, respectively. In contrast, the monoprenylated 5-deoxy-3′-prenylbiochanin
A (7) is inactive against this MRSA strain.